Vulnerability Details : CVE-2020-16198
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior. When an attacker claims to have a given identity, the software does not prove or insufficiently proves the claim is correct.
Exploit prediction scoring system (EPSS) score for CVE-2020-16198
Probability of exploitation activity in the next 30 days: 0.06%
Percentile, the proportion of vulnerabilities that are scored at or less: ~ 21 % EPSS Score History EPSS FAQ
CVSS scores for CVE-2020-16198
| Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source |
|---|---|---|---|---|---|
|
5.8
|
MEDIUM | AV:A/AC:L/Au:N/C:P/I:P/A:P |
6.5
|
6.4
|
NIST |
|
6.3
|
MEDIUM | CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L |
2.8
|
3.4
|
NIST |
CWE ids for CVE-2020-16198
-
The product does not use or incorrectly uses a protection mechanism that provides sufficient defense against directed attacks against the product.Assigned by: ics-cert@hq.dhs.gov (Primary)
References for CVE-2020-16198
-
https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01
Philips Clinical Collaboration Platform | CISAThird Party Advisory;US Government Resource
Products affected by CVE-2020-16198
- cpe:2.3:a:philips:clinical_collaboration_platform:*:*:*:*:*:*:*:*